跳至主要内容
临床试验/CTIS2023-505471-78-00
CTIS2023-505471-78-00招募中1 期

D9690C00004

Astrazeneca AB0 个研究点目标入组 14 人开始时间: 2023年6月14日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
14

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

进行中(未招募)
1 期
PET study of changes in [11C]AZ14132516 uptake following administration of multiple AZD7798 doses to patients with Crohn’s disease.Crohn's disease
CTIS2024-512992-11-00AstraZeneca AB12
招募中
1 期
Phase I study of AZD9592 in solid tumorsRecurrent or metastatic Head and NeckSquamous Cell Carcinoma of the oral cavity,oropharynx, hypopharynx or larynx, Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Metastatic Colorectal CancerMedDRA version: 20.0Level: LLTClassification code: 10079440Term: Non-squamous non-small cell lung cancer Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10001160Term: Adenocarcinoma lung Class: 10029104MedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10052358Term: Colorectal cancer metastatic Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10060121Term: Squamous cell carcinoma of head and neck Class: 100000004864MedDRA version: 21.1Level: LLTClassification code: 10029514Term: Non-small cell lung cancer NOS Class: 10029104MedDRA version: 21.0Level: PTClassification code: 10041826Term: Squamous cell carcinoma of lung Class: 100000004864
CTIS2022-501570-18-00Astrazeneca AB626
进行中(未招募)
1 期
A trial to learn how much budesonide, glycopyrronium, and formoterol fumarate (BGF) gets into and moves throughout the body when it is taken with hydrofluoroolefin (HFO) compared to when it is taken with hydrofluoroalkane (HFA) in healthy adultsot applicable, healthy volunteers
CTIS2023-504089-43-00AstraZeneca AB42
进行中(未招募)
1 期
A trial to learn how baxdrostat affects the heartbeat in healthy participants
CTIS2023-506108-23-00Astrazeneca AB28
招募中
1 期
An Open-label, Single-group, Three-period, Fixed-sequence, Phase I Study to Assess the Pharmacokinetics of AZD6793 Tablets When Administered Alone and in Combination with Itraconazole Capsules in Healthy Adult Female and Male ParticipantsChronic obstructive pulmonary diseaseMedDRA version: 26.1Level: PTClassification code: 10009033Term: Chronic obstructive pulmonary disease Class: 100000004855
CTIS2023-509002-30-00AstraZeneca AB16